De novo urological neoplasms in kidney transplant patients: Experience in 1,751 patients;Neoplasias urológicas de novo en pacientes trasplantados renales: experiencia en 1.751 pacientes

Actas Urologicas Espanolas

Volumn 34, Issue 1, 2010, Pages 88-94

  di Capua Sacoto, C ^a   Lujan Marco S ^a   Bahilo Mateu, P ^a   Budia Alba A ^a   Pontones Moreno, J L ^a   Jimenez Cruz J F ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Survival; Transplant; Tumors

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BLADDER TUMOR; DISEASE PREDISPOSITION; FEMALE; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KAPLAN MEIER METHOD; KIDNEY TRANSPLANTATION; KIDNEY TUMOR; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PROSTATE TUMOR; RETROSPECTIVE STUDY; SEX RATIO; SPAIN; STATISTICS; TRANSITIONAL CELL CARCINOMA; URINARY TRACT CANCER;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, TRANSITIONAL CELL; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSION; KAPLAN-MEIERS ESTIMATE; KIDNEY NEOPLASMS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; SPAIN; URINARY BLADDER NEOPLASMS; UROLOGIC NEOPLASMS; YOUNG ADULT;

EID: 77952110234     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0210-4806(10)70015-2     Document Type: Article

References (46)

1. Winter P., Schoeneich G., Miersch W.D., and Klehr H.U. Tumor induction as a consequence of immunosuppression after renal transplantation. Int Urol Nephrol 29 (1997) 701-709
2. Catena F., Nardo B., Liviano D'Arcangelo G., Stefoni S., Arpesella G., Faenza A., et al. De novo malignancies after organ transplantation. Transplant Proc 33 (2001) 1858-1859
3. Winkelhorst J.T., Brokelman W.J., Tiggeler R.G., and Wobbes T. Incidence and clinical course of de-novo malignancies in renal allograft recipients. Eur J Surg Oncol 27 (2001) 409-411
4. Penn I. Tumors after renal and cardiac transplantation. Hematol Oncol Clin North Am 7 (1993) 431-435
5. Sheil A.G., Disney A.P., Mathew T.G., Amiss N., and Excell L. Malignancy following renal transplantation. Transpl Proc 24 (1992) 1946-1949
6. Ramsay H.M., Fryer A.A., Reece S., Smith A.G., and Harden P.N. Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis 36 (2000) 167-170
7. Penn I. Post-transplant malignancies. Transplant Proc 31 (1999) 1260-1261
8. Sheil A.G., Disney A.P.S., Mathew T.H., and Amiss N. De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation. Transplant Proc 25 (1993) 1383-1385
9. Penn I. Primary kidney tumors before and after renal transplantation. Transplantation 59 (1995) 480-485
10. Nakano E., Iwasaki A., Seguchi T., Kokado Y., Yoshioka T., Sugao H., et al. Incidentally diagnosed renal cell carcinoma. Eur Urol 21 (1992) 294-298
11. Bretheau D., Lechevallier E., Eghazarian C., Grisoni V., and Coulange C. Prognostic significance of incidental renal cell carcinoma. Eur Urol 27 (1995) 319-323
12. European Best Practice Guidelines For Renal Transplantation. Section IV. Long term management of the transplant recipient. IV.11 Paediatrics. Nephrol Dial Transplant 17 Suppl 4 (2002) 55-58
13. Gifford R.R., Wofford J.E., and Edwards Jr. W.G. Carcinoma of the bladder in renal transplant patients. A case report and collective review of cases. Clin Transplant 12 (1998) 65-69
14. Kao Y.L., Ou Y.C., Yang C.R., Ho H.C., Su C.K., and Shu K.H. Transitional cell carcinoma in renal transplant recipients. World J Surg 27 (2003) 912-916
15. Tuttle T.M., Williams G.M., and Marshall F.F. Evidence for cyclophosphamide-induced transitional cell carcinoma in a renal transplant patient. J Urol 140 (1988) 1009-1011
16. Querci della R.G., Oliver R.T., Mc Cance D.J., and Castro J.E. Development of bladder tumour containing HPV type 11 DNA after renal transplantation. Br J Urol 62 (1988) 36-38
17. Mc Inerney P.D., Koffman C.G., and Mundy A.R. Human papillomavirus-related bladder cancer following renal transplantation. Br J Urol 72 (1993) 663-664
18. Cormier L., Lechevallier E., Barrou B., Benoit G., Bensadoun H., Boudjema K., et al. Diagnosis and treatment of prostate cancers in renal-transplant recipients. Trasplantation 75 (2003) 237-239
19. Ha R., Jindal R.M., Milgrom M.M., Leapman S.B., Filo R.S., and Pescovitz M.D. Prostate-specific antigen values and their clinical significance in renal transplant recipients. South Med J 91 (1998) 847-850
20. Malavaud B., Hoff M., Miedouge M., and Rostaing L. PSA-based screening for prostate cancer after renal transplantation. Transplantation 69 (2000) 2461-2462
21. Besarani D., and Cranston D. Urological malignancy after renal transplantation. BJU Int 100 3 (2007) 502-505
22. Chiang Y.J., Chen C.H., Wu C.T., Chu S.H., Chen Y., Liu K.L., et al. De novo cancer occurrence after renal transplantation: a medical center experience in Taiwan. Transplant Proc 36 (2004) 2150-2151
23. Gaya S.B., Rees A.J., Lecher R.I., Williams G., and Mason P.D. Malignant disease in patients with long-term renal treatments. Transplantation 59 (1995) 1705-1709
24. Birkeland S.A., Storm H.H., Lamm L.U., Barlow L., Blohmé I., Forsberg B., et al. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer 60 (1995) 183-189
25. Birkeland S.A., Lokkegarrd H., and Storm H.H. Cancer risk in patients on dialysis and after renal transplantation. Lancet 35 (2000) 1886-1887
26. Popov Z., Ivanovski O., Kolevski P., Stankov O., Petrovski D., Cakalaroski K., et al. De novo malignancies after renal transplantation--a single-center experience in the Balkans. Transplant Proc 39 8 (2007) 2589-2591
27. Navarro M.D., López-Andréu M., Rodríguez-Benot A., Agüera M.L., Del Castillo D., and Aljama P. Cancer incidence and survival in kidney transplant patients. Transplant Proc 40 9 (2008) 2936-2940
28. Vogt P., Frei U., Repp H., Bunzendahl H., Oldhafer K., Pichlmayr R., et al. Malignant tumours in renal transplant recipients receiving cyclosporin: survey of 598 first-kidney transplantations. Nephrol Dial Transplant 5 (1990) 282-288
29. Hoshida Y., Tsukuma H., Yasunaga Y., Xu N., Fujita M.Q., Satoh T., et al. Cancer risk after renal transplantation in Japan. Int J Cancer 71 (1997) 517-520
30. Ochiai T., Ascano T., and Isono K. Development of malignancies in Japanese renal-transplant recipients. Transplant Proc 14 (1987) 2967-2970
31. Fuente M.J., Sabat M., Roca J., Lauzurica R., Fernández-Figueras M.T., and Ferrándiz C. A prospective study of the incidence of skin cancer and its risk factors in a Spanish Mediterranean population of kidney transplant recipients. Br J Dermatol 149 6 (2003) 1221-1226
32. Martínez Jabaloyas J.M., Ruiz Cerdá J.L., Osca J.M., Perales Ruiz J.L., Alfonso Gil R., Pallardo L., et al. Neoplasias en trasplantados renales. Actas Urol Esp 18 5 (1994) 562-568
33. Lampreabe I., Gómez-Ullate P., Amenábar J.J., Zárraga S., and Gaínza F.J. Presentation of cancers in recipients of a solid-organ transplant. Nefrologia 21 6 (2001) 528-537
34. B esarani D., Roy D., Muthusamy A., et al. Solid organ malignancies after renal transplantation: Oxford experience in the last 3 decades. British Transplantation Society Annual Meeting. Edinburgh (2006)
35. B ruun L., Ekberg H., Björk T., Lilja H., Høglund P., Christensson A., et al. Rapid elimination by glomerular filtration of free prostate specific antigen and human kallikrein 2 after renal transplantation. J Urol 171 (2004) 1432-1435
36. Hafron J., Fogarty J.D., Wiesen A., and Melman A. Surgery for localized prostate cancer after renal transplantation. BJU Int 95 (2005) 319-322
37. Krochak R.J., and Baker D.G. Radiation nephritis. Clinical manifestations and pathophysiologic mechanisms. Urology 27 (1987) 389-393
38. Thomas A.A., Nguyen M.M., and Gill I.S. Laparoscopic transperitoneal radical prostatectomy in renal transplant recipients: a review of three cases. Urology 71 2 (2008) 205-208
39. Shah K.K., Ko D.S., Mercer J., and Dahl D.M. Laparoscopic radical prostatectomy in a renal allograft recipient. Urology 68 (2006) 672-677
40. Master V.A., Meng M.V., Grossfeld G.D., Koppie T.M., Hirose R., and Carroll P.R. Treatment and outcome of invasive bladder cancer in patients after renal transplantation. J Urol 171 (2004) 1085-1087
41. Roberts I.S., Besarani D., Mason P., Turner G., Friend P.J., and Newton R. Polyoma virus infection and urothelial carcinoma of the bladder following renal transplantation. Br J Cancer 99 9 (2008) 1383-1386
42. Neuzillet Y., Davin J.L., and Lechevallier E. Intravesical BCG instillations for the treatment of superficial bladder tumours in renal transplant recipients. Prog Urol 16 (2006) 32-35
43. Kamal M.M., Soliman S.M., Shokeir A.A., Abol-Enein H., and Ghoneim M.A. Bladder carcinoma among live-donor renal transplant recipients: a single-centre experience and a review of the literature. BJU Int 101 1 (2008) 30-35
44. Lang H., de Petriconi R., Wenderoth U., Volkmer B.G., Hautmann R.E., and Gschwend J.E. Orthotopic ileal neobladder reconstruction in patients with bladder cancer following renal transplantation. J Urol 173 (2005) 881-884
45. Chambade D., Meria P., Tariel E., Vérine J., De Kerviler E., Peraldi M.N., et al. Nephron sparing surgery is a feasible and efficient treatment of T1a renal cell carcinoma in kidney transplant: a prospective series from a single center. J Urol 180 5 (2008) 2106-2109
46. Ribal M.J., Rodríguez F., Musquera M., Segarra J., Guirado L., Villavicencio H., et al. Nephron-sparing surgery for renal tumor: a choice of treatment in an allograft kidney. Transplant Proc 38 5 (2006) 1359-1362